Committee for Orphan Medicinal Products (COMP): 16-18 January 2024

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

Date

Tuesday, 16 January 2024, All day
Thursday, 18 January 2024, All day

Location

European Medicines Agency, Amsterdam, the Netherlands

Documents

Share this page